Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of Internal Medicine
The potential of the antiviral combo in reducing the risk of thromboembolic events among post-COVID-19 patients is real. Could it pave the way for more targeted therapeutic strategies in managing post-COVID-19 conditions?
All Specialties November 8th 2023
CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH 